• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by UFP Technologies Inc. (Amendment)

    9/8/23 10:20:06 AM ET
    $UFPT
    Medical/Dental Instruments
    Health Care
    Get the next $UFPT alert in real time by email
    SC 13G/A 1 formsc13ga-09082023_020903.htm FORM schedule-13g


     
     


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    SCHEDULE 13G/A
    Under the Securities Exchange Act of 1934
    (Amendment No. 1)*


     
    UFP TECHNOLOGIES INC
    (Name of Issuer)
    COMMON
    (Title of Class of Securities)
    902673102
    (CUSIP Number)
    August 31, 2023
    (Date of Event Which Requires Filing of this Statement)
    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    [ x ] Rule 13d-1(b)

    [   ] Rule 13d-1(c)

    [   ] Rule 13d-1(d)



    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
     
     


     
    CUSIP No. 902673102
      (1)   

    Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)

     

        Neuberger Berman Group LLC

        61-1591182

      (2)  
    Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  
    (b)   Membership in Group is Disclaimed
      (3)  

    SEC Use Only

     

      (4)  

    Citizenship or Place of Organization

     

        Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       (5)    

    Sole Voting Power

     

        0

       (6)   

    Shared Voting Power

     

        761,374

       (7)   

    Sole Dispositive Power

     

        0

       (8)   

    Shared Dispositive Power

     

        769,861

    (9)

     

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

        769,861

    (10)

     

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares     [ x ]

     

        (See Instructions)

    (11)

     

    Percent of Class Represented by Amount in Row (9)

     

        10.08%

    (12)

     

    Type of Reporting Person (See Instructions)

     

        HC


    CUSIP No. 902673102
      (1)   

    Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)

     

        Neuberger Berman Investment Advisers LLC

        02-0654486

      (2)  
    Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  
    (b)   Membership in Group is Disclaimed
      (3)  

    SEC Use Only

     

      (4)  

    Citizenship or Place of Organization

     

        Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       (5)    

    Sole Voting Power

     

        0

       (6)   

    Shared Voting Power

     

        761,301

       (7)   

    Sole Dispositive Power

     

        0

       (8)   

    Shared Dispositive Power

     

        769,788

    (9)

     

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

        769,788

    (10)

     

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares     [ x ]

     

        (See Instructions)

    (11)

     

    Percent of Class Represented by Amount in Row (9)

     

        10.08%

    (12)

     

    Type of Reporting Person (See Instructions)

     

        IA


    CUSIP No. 902673102
      (1)   

    Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)

     

        Neuberger Berman Equity Funds

        13-6068441

      (2)  
    Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  
    (b)   Membership in Group is Disclaimed
      (3)  

    SEC Use Only

     

      (4)  

    Citizenship or Place of Organization

     

        Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       (5)    

    Sole Voting Power

     

        0

       (6)   

    Shared Voting Power

     

        515,543

       (7)   

    Sole Dispositive Power

     

        0

       (8)   

    Shared Dispositive Power

     

        515,543

    (9)

     

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

        515,543

    (10)

     

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares   [   ]

     

        (See Instructions)

    (11)

     

    Percent of Class Represented by Amount in Row (9)

     

        6.75%

    (12)

     

    Type of Reporting Person (See Instructions)

     

        IV


    CUSIP No. 902673102
      (1)   

    Names of Reporting Persons/ I.R.S. Identification Nos. of Above Persons (Entities Only)

     

        Neuberger Berman Genesis Fund

        13-3697433

      (2)  
    Check the Appropriate Box if a Member of a Group (See Instructions)
    (a)  
    (b)   Membership in Group is Disclaimed
      (3)  

    SEC Use Only

     

      (4)  

    Citizenship or Place of Organization

     

        Delaware

    Number of

    Shares

    Beneficially

    Owned by

    Each

    Reporting

    Person

    With

       (5)    

    Sole Voting Power

     

        0

       (6)   

    Shared Voting Power

     

        515,543

       (7)   

    Sole Dispositive Power

     

        0

       (8)   

    Shared Dispositive Power

     

        515,543

    (9)

     

    Aggregate Amount Beneficially Owned by Each Reporting Person

     

        515,543

    (10)

     

    Check if the Aggregate Amount in Row (9) Excludes Certain Shares   [   ]

     

        (See Instructions)

    (11)

     

    Percent of Class Represented by Amount in Row (9)

     

        6.75%

    (12)

     

    Type of Reporting Person (See Instructions)

     

        IV


    Item 1.
    (a) Name of Issuer
    UFP TECHNOLOGIES INC
    (b) Address of Issuer's Principal Executive Offices
    100 HALE STREET
    NEWBURYPORT, Massachusetts, 01950

    Item 2.
    (a) Name of Person Filing
    Neuberger Berman Group LLC
    Neuberger Berman Investment Advisers LLC
    Neuberger Berman Equity Funds
    Neuberger Berman Genesis Fund
    (b) Address of Principal Business Office or, if none, Residence
    1290 Avenue of the Americas
    New York, NY 10104
    (c) Citizenship
    Delaware
    (d) Title of Class of Securities
    COMMON
    (e) CUSIP Number
    902673102

    Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)
    [   ]
    Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)
    [   ]
    Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)
    [   ]
    Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)
    [   ]
    Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);
    (e)
    [   ]
    An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
    (f)
    [   ]
    An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
    (g)
    [   ]
    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)
    [   ]
    A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)
    [   ]
    A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)
    [ x ]
    Group, in accordance with §240.13d-1(b)(1)(ii)(J).

    Item 4.
    (a) Amount beneficially owned:
    769,861

    Neuberger Berman Trust Co N.A., Neuberger Berman Trust Co of Delaware N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC, and Neuberger Berman Investment Advisers LLC and certain affiliated persons may be deemed to beneficially own the securities covered by this report in their various fiduciary capacities by virtue of the provisions of Exchange Act Rule 13d-3. Neuberger Berman Group LLC, through its subsidiaries Neuberger Berman Investment Advisers Holdings LLC and Neuberger Trust Holdings LLC controls Neuberger Berman Trust Co N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC, Neuberger Berman Trust Co of Delaware N.A. and Neuberger Berman Investment Advisers LLC and certain affiliated persons.

    This report is not an admission that any of these entities are the beneficial owner of the securities covered by this report and each of Neuberger Berman Group LLC, Neuberger Berman Investment Advisers Holdings LLC, Neuberger Trust Holdings LLC, Neuberger Berman Trust Co N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC, Neuberger Berman Trust Co of Delaware N.A. and Neuberger Berman Investment Advisers LLC and certain affiliated persons disclaim beneficial ownership of the securities covered by this statement pursuant to Exchange Act Rule 13d-4.

    The information in this filing reports securities of the issuer that may be deemed to be beneficially owned by Neuberger Berman Group LLC, Neuberger Berman Investment Advisers Holdings LLC, Neuberger Trust Holdings LLC, Neuberger Berman Trust Co N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC, Neuberger Berman Trust Co of Delaware N.A. and Neuberger Berman Investment Advisers LLC ("NBG Filers"). The securities of the issuer, if any, that may be deemed to be beneficially owned by NB Alternatives Advisers LLC and other subsidiaries of Neuberger Berman Group LLC that are separated from the NBG Filers by an information barrier in accordance with SEC Release No. 34-39538 (January 12, 1998) are not reflected in this filing.
    (b) Percent of class:
    10.08%
    (c) Number of shares as to which the person has:
    (i) Sole power to vote or to direct the vote
    0
    (ii) Shared power to vote or to direct the vote
    761,374
    (iii) Sole power to dispose or to direct the disposition of
    0
    (iv) Shared power to dispose or to direct the disposition of
    769,861

    Item 5. Ownership of Five Percent or Less of a Class
    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [   ]

    Item 6. Ownership of More than Five Percent on Behalf of Another Person.
    Neuberger Berman Group LLC and its affiliates may be deemed to be beneficial owners of securities for purposes of Exchange Act Rule 13d-3 because they or certain affiliated persons have shared power to retain, dispose of or vote the securities of unrelated clients. Neuberger Berman Group LLC or its affiliated persons do not, however, have any economic interest in the securities of those clients. The clients have the sole right to receive and the power to direct the receipt of dividends from or proceeds from the sale of such securities. Other than named in this filing, no one client has an interest of more than 5% of the issuer.

    With regard to the shares set forth under item 4(c)(ii), Neuberger Berman Group LLC may be deemed to be the beneficial owner for purposes of Rule 13d-3 because certain affiliated persons have shared power to retain, dispose of and vote the securities. In addition to the holdings of individual advisory clients, Neuberger Berman Investment Advisers LLC serves as investment manager of Neuberger Berman Group LLC's various registered mutual funds which hold such shares. The holdings belonging to clients of Neuberger Berman Trust Co N.A., Neuberger Berman Trust Co of Delaware N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC and Neuberger Berman Investment Advisers LLC are also aggregated to comprise the holdings referenced herein.

    In addition to the shares set forth under Item 4(c)(ii) for which Neuberger entities also have shared power to dispose of the shares, item 4(c)(iv) also includes shares from individual client accounts over which Neuberger Berman Investment Advisers LLC has shared power to dispose but does not have voting power over these shares. The holdings of Neuberger Berman Trust Co N.A., Neuberger Berman Trust Co of Delaware N.A., Neuberger Berman Asia Ltd., Neuberger Berman Canada ULC and Neuberger Berman Investment Advisers LLC, are also aggregated to comprise the holdings referenced herein.

    Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.
    N/A

    Item 8. Identification and Classification of Members of the Group.
    N/A

    Item 9. Notice of Dissolution of Group.
    N/A

    Item 10. Certification.
    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
     


     
    SIGNATURES
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
     
    Date:   September 8, 2023
    Neuberger Berman Group LLC
    By: /s/ Brad Cetron

    Name: Brad Cetron
    Title: Deputy General Counsel
    Date:   September 8, 2023
    Neuberger Berman Investment Advisers LLC
    By: /s/ Brad Cetron

    Name: Brad Cetron
    Title: Deputy General Counsel
    Date:   September 8, 2023
    Neuberger Berman Equity Funds
    By: /s/ Brian Kerrane

    Name: Brian Kerrane
    Title: Chief Operating Officer
    Date:   September 8, 2023
    Neuberger Berman Genesis Fund
    By: /s/ Brian Kerrane

    Name: Brian Kerrane
    Title: Chief Operating Officer


    Get the next $UFPT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UFPT

    DatePrice TargetRatingAnalyst
    3/28/2025Mkt Perform
    Raymond James
    7/17/2024$344.00 → $392.00Buy
    Lake Street
    3/20/2024Market Outperform
    CJS Securities
    2/6/2024Sector Weight
    KeyBanc Capital Markets
    12/21/2022$124.00Buy
    Lake Street
    6/22/2022$110.00Buy
    Lake Street
    11/19/2021$81.00Buy
    Colliers Securities
    More analyst ratings

    $UFPT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by UFP Technologies Inc.

      SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

      11/13/24 9:58:23 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G/A filed by UFP Technologies Inc. (Amendment)

      SC 13G/A - UFP TECHNOLOGIES INC (0000914156) (Subject)

      3/8/24 3:02:25 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by UFP Technologies Inc.

      SC 13G - UFP TECHNOLOGIES INC (0000914156) (Subject)

      2/13/24 5:16:09 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    Financials

    Live finance-specific insights

    See more
    • UFP Technologies Announces Record Q1 Results

      NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted n

      5/6/25 9:00:56 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025

      NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time. Conference Call Information:Date: Tuesday, May 6, 2025Time: 10:00 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live webcast of t

      4/30/25 9:00:43 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025

      NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th. About UFP Technologies, Inc. UFP Technologies is an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products. UFP is an important link in the medical device supply chain and a valued outsource partner to man

      2/19/25 9:00:38 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care

    $UFPT
    Leadership Updates

    Live Leadership Updates

    See more
    • UFP Technologies Acquires AQF Medical

      NEWBURYPORT, Mass., Aug. 26, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of AQF Limited ("AQF Medical"). Headquartered in Navan, Ireland with additional joint venture operations in Singapore, AQF Medical develops and manufactures custom-engineered foam and thermoplastic components used in a wide range of medical devices and packaging. "We are excited about the addition of AQF Medical, our fourth acquisition in the past few months," said R. Jeffrey Bailly, Chairman and CEO of UFP Technologies.

      8/26/24 9:00:00 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies Acquires Marble Medical

      NEWBURYPORT, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engineered custom products, today announced the acquisition of Marble Medical. Founded in 1988 and headquartered in Tallahassee, FL, Marble Medical develops and manufactures adhesive based medical components and single-use devices. "Adding Marble Medical's adhesives expertise is a great complement to our surgical robot drapes and stick to skin device platforms," said R. Jeffrey Bailly, chairman and CEO of UFP Technologies. "Marble Medical is a 3M Preferred Converter, and along wi

      7/16/24 4:05:00 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Chimerix Appoints Marc D. Kozin to Board of Directors

      DURHAM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced the appointment of Marc D. Kozin as the newest member of the Company's Board of Directors. In addition, Patrick Machado has announced his retirement from the Chimerix Board effective at the Company's 2024 Annual Meeting of Stockholders in June, after ten years of service. "We are pleased to welcome Marc to the Board of Directors. Marc's strategic insights and leadership will undoubtedly contribute to the continued growth and success of Chimerix as we wo

      3/21/24 7:00:00 AM ET
      $CMRX
      $UFPT
      Biotechnology: Pharmaceutical Preparations
      Health Care
      Medical/Dental Instruments

    $UFPT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more

    $UFPT
    SEC Filings

    See more

    $UFPT
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $UFPT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more

    $UFPT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Raymond James initiated coverage on UFP Technologies

      Raymond James initiated coverage of UFP Technologies with a rating of Mkt Perform

      3/28/25 8:21:18 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Lake Street reiterated coverage on UFP Technologies with a new price target

      Lake Street reiterated coverage of UFP Technologies with a rating of Buy and set a new price target of $392.00 from $344.00 previously

      7/17/24 8:57:19 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • CJS Securities initiated coverage on UFP Technologies

      CJS Securities initiated coverage of UFP Technologies with a rating of Market Outperform

      3/20/24 9:43:53 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form 144 filed by UFP Technologies Inc.

      144 - UFP TECHNOLOGIES INC (0000914156) (Subject)

      5/8/25 3:49:36 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - UFP TECHNOLOGIES INC (0000914156) (Filer)

      5/7/25 8:39:37 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form DEF 14A filed by UFP Technologies Inc.

      DEF 14A - UFP TECHNOLOGIES INC (0000914156) (Filer)

      4/30/25 12:05:31 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies Announces Record Q1 Results

      NEWBURYPORT, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), a designer and custom manufacturer of comprehensive solutions primarily for the medical market, today reported net income of $17.2 million or $2.21 per diluted common share outstanding for its first quarter ended March 31, 2025, compared to net income of $12.7 million or $1.64 per diluted common share outstanding for the first quarter of 2024. Net Sales for the first quarter were $148.1 million compared to 2024 first quarter sales of $105.0 million. Throughout this news release, reference is made to non-GAAP measures including organic sales growth, adjusted operating income, adjusted SG&A, adjusted n

      5/6/25 9:00:56 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Report First Quarter 2025 Financial Results on May 6, 2025

      NEWBURYPORT, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an innovative designer and custom manufacturer of components for medical devices, sterile packaging, and other highly engineered products, today announced the Company plans to report financial results for the first quarter ended March 31, 2025 on May 6, 2025 prior to market open. The Company will hold a conference call to discuss results the same day at 10:00 AM Eastern time. Conference Call Information:Date: Tuesday, May 6, 2025Time: 10:00 AM Eastern TimeParticipants may join the call using the following dial-in numbers: Toll-Free: 1-888-243-4451International: 1-412-542-4135 A live webcast of t

      4/30/25 9:00:43 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum

      NEWBURYPORT, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (NASDAQ:UFPT), an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets Healthcare Forum to be held virtually on March 18, 2025. UFP's presentation is scheduled to begin at 10:30 AM ET. About UFP Technologies, Inc.UFP Technologies is a designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging, and other highly engine

      3/17/25 9:00:01 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Lataille Ronald J bought $91,636 worth of shares (400 units at $229.09), increasing direct ownership by 3% to 15,031 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      2/27/25 3:57:17 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • SEC Form 4 filed by Lataille Ronald J

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      11/13/23 11:09:49 AM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Rock Mitchell bought $27,522 worth of shares (198 units at $139.00), increasing direct ownership by 0.74% to 27,086 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      11/9/23 5:21:17 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Vice President Holt Jason covered exercise/tax liability with 462 shares, decreasing direct ownership by 6% to 7,848 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      3/5/25 8:02:14 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Vice President Cardin Steve covered exercise/tax liability with 623 shares, decreasing direct ownership by 10% to 5,623 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      3/5/25 7:59:35 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care
    • Senior Vice President Litterio Christopher P. covered exercise/tax liability with 921 shares, decreasing direct ownership by 6% to 14,058 units (SEC Form 4)

      4 - UFP TECHNOLOGIES INC (0000914156) (Issuer)

      3/5/25 7:54:06 PM ET
      $UFPT
      Medical/Dental Instruments
      Health Care